Ozempic has emerged as a prominent treatment option for managing type 2 diabetes, and its reach expands deeper into obesity management. As a GLP-1 receptor agonist, it plays a critical role in regulating blood sugar levels, stimulating insulin secretion, and enhancing feelings of fullness after meals. Its active ingredient, semaglutide,…